Veterinary albendazole ivermectin premixing agent and preparation method thereof

A technology of albendazole ivermectin and ivermectin, which is applied in the field of veterinary albendazole ivermectin premix and its preparation, and can solve the problems affecting the main components of albendazole and ivermectin. To solve problems such as mycocin detection, small dosage of ivermectin, and detection content not up to the standard, to achieve the effect of low static electricity, reasonable selection, and convenient operation

Active Publication Date: 2017-02-15
FOSHAN STANDARD BIO TECH
View PDF8 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] According to the existing preparation method, there are mainly the following problems: (1) The dosage of ivermectin is small, and it is not easy to mix evenly. When the mixed feed is used, poisoning accidents often occur because of the inability to mix evenly.
[0009] (2) The biggest feature of activated carbon is its fast decolorization speed and strong adsorption capacity. After it is mixed with ivermectin and albendazole, it can absorb these two main drugs and affect the mai

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Veterinary albendazole ivermectin premixing agent and preparation method thereof
  • Veterinary albendazole ivermectin premixing agent and preparation method thereof
  • Veterinary albendazole ivermectin premixing agent and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0033] Example 1

[0034] The veterinary albendazole and ivermectin premix of the present invention includes the following components by mass percentage:

[0035]

[0036] The ivermectin pretreatment agent is a combination of four of lecithin, hydrogenated castor oil, and hydrogenated soybean oil. The auxiliary material is a combination of two kinds of calcium carbonate and sodium citrate.

[0037] The preparation method of the veterinary albendazole and ivermectin premix of the present invention includes the following steps:

[0038] (1) Ivermectin pretreatment:

[0039] Accurately weigh each component according to the stated mass percentage for use;

[0040] Take ivermectin pretreatment agent, heat and melt; heating temperature is 100 ℃, add ivermectin, shear and stir uniformly; spray condensation granulation of the prepared mixture, the particle size of the prepared granules is 90 μm , Sieve to obtain A powder;

[0041] (2) Albendazole is evenly mixed with 150μm crushed anhydrous glu...

Example Embodiment

[0043] Example 2

[0044] The difference between Example 2 and Example 1 is that: a premix for veterinary albendazole and ivermectin of the present invention includes the following components by mass percentage:

[0045]

[0046] The ivermectin pretreatment agent is wax. The waxes are four combinations of white wax, paraffin wax, insect wax or beeswax. The auxiliary material is sodium citrate.

[0047] The preparation method of the veterinary albendazole and ivermectin premix of the present invention includes the following steps:

[0048] (1) Ivermectin pretreatment:

[0049] Accurately weigh each component according to the stated mass percentage for use;

[0050] Take ivermectin pretreatment agent and heat and melt; heating temperature is 80 ℃, add ivermectin, shear and stir uniformly; spray condensation granulation of the prepared mixture, the particle size of the prepared granules is 180μm, A powder is obtained by sieving;

[0051] In step (2), albendazole is uniformly mixed with 15...

Example Embodiment

[0053] Example 3

[0054] The difference between Example 3 and Example 1 is that: a veterinary albendazole and ivermectin premix of the present invention includes the following components by mass percentage:

[0055]

[0056] The ivermectin pretreatment agent is a combination of Tween, lecithin, and hydrogenated castor oil. The auxiliary material is silica.

[0057] The preparation method of the veterinary albendazole and ivermectin premix of the present invention includes the following steps:

[0058] In step (1), ivermectin pretreatment:

[0059] Accurately weigh each component according to the stated mass percentage for use;

[0060] Take ivermectin pre-treatment agent, heat and melt; heating temperature is 110 ℃, add ivermectin, shear and stir uniformly; spray condensation granulation of the prepared mixture, and the particle size of the prepared granules is 150 μm , Sieve to obtain A powder;

[0061] In step (2), albendazole is uniformly mixed with 150 μm crushed anhydrous glucose ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention discloses a veterinary albendazole ivermectin premixing agent and a preparation method thereof. The veterinary albendazole ivermectin premixing agent disclosed by the invention comprises the following components in percentage by weight: 5.5-6.5 percent of albendazole, 0.22-0.26 percent of ivermectin, 5-15 percent of medicinal carbon, 5-10 percent of dextrose anhydrous, 30-59 percent of maize starch, 10-15 percent of an ivermectin pretreatment agent and the balance of an auxiliary material. The preparation method disclosed by the invention is simple in process, convenient to operate and easy to industrialize, and the product prepared by the preparation method disclosed by the invention is uniform in particle size, low in static electricity and good in uniformity.

Description

technical field [0001] The invention relates to the field of veterinary medicine, in particular to a veterinary albendazole ivermectin premix and a preparation method thereof. Background technique [0002] Albendazole: It has a broad-spectrum deworming activity, and has a strong killing effect on nematodes, tapeworms and trematodes. Its mechanism of action is to bind to tubulin in worms and prevent it from multimerizing with α-tubulin to form microtubules, thereby affecting cell reproduction processes such as mitosis, protein assembly and energy metabolism in worms. [0003] Ivermectin: It has a good repellent effect on internal and external parasites, especially arthropod insects and internal nematodes, and is mainly used to expel gastrointestinal nematodes, lung nematodes and external parasites in pigs. Its deworming mechanism is to promote the release of γ-aminobutyric acid (GABA) from presynaptic neurons, thereby opening the GABA-mediated chloride ion channel. The chlo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/7048A61K31/4184A61K9/16A61K47/36A61K47/26A61K47/04A61K47/24A61K47/44
CPCA61K9/1611A61K9/1617A61K9/1623A61K9/1652A61K31/4184A61K31/7048A61K2300/00
Inventor 刘肖娟谭志坚翁亚彪符德文袁增辉黎剑坤陈艺青
Owner FOSHAN STANDARD BIO TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap